Dentsply International Inc. (XRAY)

$26.41

-0.02

(-0.08%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $26.25
    $26.63
    $26.41
    downward going graph

    0.61%

    Downside

    Day's Volatility :1.43%

    Upside

    0.83%

    downward going graph
  • $23.95
    $40.07
    $26.41
    downward going graph

    9.31%

    Downside

    52 Weeks Volatility :40.23%

    Upside

    34.09%

    downward going graph

Returns

PeriodDentsply International Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-13.54%
6.5%
0.0%
6 Months
-24.31%
7.1%
0.0%
1 Year
-34.69%
9.8%
0.0%
3 Years
-58.46%
14.2%
-20.2%

Highlights

Market Capitalization
5.4B
Book Value
$15.69
Dividend Share
0.58
Dividend Yield
2.44%
Earnings Per Share (EPS)
-0.44
PEG Ratio
1.53
Wall Street Target Price
33.04
Profit Margin
-2.41%
Operating Margin TTM
5.25%
Return On Assets TTM
2.38%
Return On Equity TTM
-2.67%
Revenue TTM
3.9B
Revenue Per Share TTM
18.74
Quarterly Revenue Growth YOY
-2.6%
Gross Profit TTM
2.1B
EBITDA
627.0M
Diluted Eps TTM
-0.44
Quarterly Earnings Growth YOY
0.18
EPS Estimate Current Year
2.02
EPS Estimate Next Year
2.37
EPS Estimate Current Quarter
0.42
EPS Estimate Next Quarter
0.54

Analyst Recommendation

Buy
    59%Buy
    40%Hold
    0
    0%Sell
Based on 22 Wall street analysts offering stock ratings for Dentsply International Inc.(by analysts ranked 0 to 5 stars)
Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
12
Hold
9
9
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 25.1%

Current $26.41
Target $33.04

Company Financials

FY18Y/Y Change
Revenue
4.0B
↓ 0.18%
Net Income
-1.0B
↓ 35.73%
Net Profit Margin
-25.36%
↑ 14.03%
FY19Y/Y Change
Revenue
4.0B
↑ 1.08%
Net Income
262.9M
↓ 126.0%
Net Profit Margin
6.52%
↑ 31.88%
FY20Y/Y Change
Revenue
3.3B
↓ 17.06%
Net Income
-83.0M
↓ 131.57%
Net Profit Margin
-2.48%
↓ 9.0%
FY21Y/Y Change
Revenue
4.3B
↑ 27.2%
Net Income
411.0M
↓ 595.18%
Net Profit Margin
9.67%
↑ 12.15%
FY22Y/Y Change
Revenue
3.9B
↓ 7.74%
Net Income
-950.0M
↓ 331.14%
Net Profit Margin
-24.22%
↓ 33.89%
FY23Y/Y Change
Revenue
4.0B
↑ 1.1%
Net Income
-132.0M
↓ 86.11%
Net Profit Margin
-3.33%
↑ 20.89%
Q4 FY22Q/Q Change
Revenue
983.0M
↑ 1.87%
Net Income
-15.0M
↓ 121.74%
Net Profit Margin
-1.53%
↓ 8.68%
Q1 FY23Q/Q Change
Revenue
978.0M
↓ 0.51%
Net Income
-23.0M
↑ 53.33%
Net Profit Margin
-2.35%
↓ 0.82%
Q2 FY23Q/Q Change
Revenue
1.0B
↑ 5.11%
Net Income
86.0M
↓ 473.91%
Net Profit Margin
8.37%
↑ 10.72%
Q3 FY23Q/Q Change
Revenue
947.0M
↓ 7.88%
Net Income
-266.0M
↓ 409.3%
Net Profit Margin
-28.09%
↓ 36.46%
Q4 FY23Q/Q Change
Revenue
1.0B
↑ 6.86%
Net Income
67.0M
↓ 125.19%
Net Profit Margin
6.62%
↑ 34.71%
Q1 FY24Q/Q Change
Revenue
953.0M
↓ 5.83%
Net Income
18.0M
↓ 73.13%
Net Profit Margin
1.89%
↓ 4.73%
FY18Y/Y Change
Total Assets
8.7B
↓ 16.31%
Total Liabilities
3.6B
↓ 4.94%
FY19Y/Y Change
Total Assets
8.6B
↓ 0.97%
Total Liabilities
3.5B
↓ 1.29%
FY20Y/Y Change
Total Assets
9.3B
↑ 8.59%
Total Liabilities
4.4B
↑ 24.63%
FY21Y/Y Change
Total Assets
9.2B
↓ 1.31%
Total Liabilities
4.2B
↓ 4.46%
FY22Y/Y Change
Total Assets
7.6B
↓ 17.1%
Total Liabilities
3.8B
↓ 8.28%
FY23Y/Y Change
Total Assets
7.4B
↓ 3.57%
Total Liabilities
4.1B
↑ 6.4%
Q4 FY22Q/Q Change
Total Assets
7.6B
↓ 16.56%
Total Liabilities
3.8B
↓ 9.94%
Q1 FY23Q/Q Change
Total Assets
7.7B
↑ 0.39%
Total Liabilities
4.0B
↑ 5.32%
Q2 FY23Q/Q Change
Total Assets
7.7B
↓ 0.3%
Total Liabilities
3.9B
↓ 2.16%
Q3 FY23Q/Q Change
Total Assets
7.2B
↓ 5.87%
Total Liabilities
3.8B
↓ 2.99%
Q4 FY23Q/Q Change
Total Assets
7.4B
↑ 2.35%
Total Liabilities
4.1B
↑ 6.42%
Q1 FY24Q/Q Change
Total Assets
7.1B
↓ 3.35%
Total Liabilities
3.9B
↓ 5.18%
FY18Y/Y Change
Operating Cash Flow
499.8M
↓ 16.96%
Investing Cash Flow
-253.3M
↓ 11.56%
Financing Cash Flow
-249.8M
↓ 37.67%
FY19Y/Y Change
Operating Cash Flow
632.8M
↑ 26.61%
Investing Cash Flow
-68.4M
↓ 73.0%
Financing Cash Flow
-466.1M
↑ 86.59%
FY20Y/Y Change
Operating Cash Flow
635.0M
↑ 0.35%
Investing Cash Flow
-1.1B
↑ 1516.96%
Financing Cash Flow
490.0M
↓ 205.13%
FY21Y/Y Change
Operating Cash Flow
657.0M
↑ 3.46%
Investing Cash Flow
-358.0M
↓ 67.63%
Financing Cash Flow
-379.0M
↓ 177.35%
FY22Y/Y Change
Operating Cash Flow
517.0M
↓ 21.31%
Investing Cash Flow
-138.0M
↓ 61.45%
Financing Cash Flow
-329.0M
↓ 13.19%
Q4 FY22Q/Q Change
Operating Cash Flow
142.0M
↑ 52.69%
Investing Cash Flow
-29.0M
↓ 27.5%
Financing Cash Flow
-161.0M
↑ 1510.0%
Q1 FY23Q/Q Change
Operating Cash Flow
-21.0M
↓ 114.79%
Investing Cash Flow
-37.0M
↑ 27.59%
Financing Cash Flow
17.0M
↓ 110.56%
Q2 FY23Q/Q Change
Operating Cash Flow
104.0M
↓ 595.24%
Investing Cash Flow
-29.0M
↓ 21.62%
Financing Cash Flow
-87.0M
↓ 611.76%
Q3 FY23Q/Q Change
Operating Cash Flow
134.0M
↑ 28.85%
Investing Cash Flow
-2.0M
↓ 93.1%
Financing Cash Flow
-109.0M
↑ 25.29%

Technicals Summary

Sell

Neutral

Buy

Dentsply International Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Dentsply International Inc.
Dentsply International Inc.
5.05%
-24.31%
-34.69%
-58.46%
-52.82%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.32%
16.54%
32.6%
35.62%
148.32%
Resmed Inc.
Resmed Inc.
11.69%
9.57%
-6.0%
-19.79%
64.22%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.5%
-1.64%
-17.69%
-6.68%
-8.49%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.37%
-23.3%
-26.95%
-26.58%
102.44%
Alcon Ag
Alcon Ag
2.41%
20.84%
8.21%
30.7%
54.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Dentsply International Inc.
Dentsply International Inc.
22.28
NA
1.53
2.02
-0.03
0.02
0.02
15.69
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
78.14
78.14
7.13
6.63
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
32.24
32.24
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.71
50.71
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
44.05
44.05
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Dentsply International Inc.
Dentsply International Inc.
Buy
$5.4B
-52.82%
22.28
-2.41%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$161.3B
148.32%
78.14
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
64.22%
32.24
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$68.6B
-8.49%
50.71
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.7B
102.44%
42.71
19.42%
Alcon Ag
Alcon Ag
Buy
$45.8B
54.72%
44.05
10.96%

Insights on Dentsply International Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.01B → 953.0M (in $), with an average decrease of 5.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 67.0M → 18.0M (in $), with an average decrease of 73.1% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 67.3%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 94.1%

Institutional Holdings

  • Vanguard Group Inc

    11.99%

  • BlackRock Inc

    6.36%

  • Mariner Value Strategies, LLC

    5.05%

  • Arnhold & S. Bleichroeder Advisers, LLC

    4.71%

  • T. Rowe Price Investment Management,Inc.

    4.17%

  • State Street Corporation

    3.92%

Corporate Announcements

  • Dentsply International Inc. Dividends March,2024

    In the quarter ending March,2024. Dentsply International Inc. has declared dividend of $0.16

    Read More

Company Information

a global total solutions provider dentsply sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. dentsply sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. as the dental solutions company™, dentsply sirona provides dental professionals a comprehensive end-to-end solutions offering. this offering includes some of the best-known and established brands in the industry. we develop, manufacture and market a complete line of dental and oral health products, including gener

Organization
Dentsply International Inc.
Employees
15000
CEO
Mr. Simon D. Campion
Industry
Health Technology

Discover More

FAQs